The critical role of IgM in controlling pathogen burden has been demonstrated in a variety of infection models. In the murine model of Borrelia hermsii infection, IgM is necessary and sufficient for the rapid clearance of bacteremia. Convalescent, but not naïve, B1b cells generate an IgM-mediated protective response against B. hermsii, but the mechanisms of control are unknown. Here we show that neither Fcα/µR, a high-affinity receptor for IgM that mediates opsonophagocytosis, nor IgM-dependent complement-activation were required for controlling B.
. Reconstitution of immunodeficient Rag1 -/-mice (lacking T and B cells) with expanded B1b cells from convalescent mice confers complete immunity, whereas reconstitution with naive B1b cells provides only partial protection, demonstrating that convalescent B1b cells have acquired immunological memory [15] . Like conventional memory B cells, the reconstituted population persists but does not spontaneously secrete B. hermsii-specific antibodies; rather they maintain quiescence. Upon a subsequent exposure to antigen, however, memory-like B1b cells rapidly differentiate into antigen-specific
IgM secreting plasma cells, resulting in a specific antibody response that is faster and to a greater magnitude than that of naïve B1b cells [15] . Although the lymphocyte subsets that respond to B.
hermsii and FhBA, a surface protein of B. hermsii that is recognized by B1b cell-derived IgM has been defined [15, 16] , it is not clear how such IgM controls this infection in vivo.
The pentameric structure of IgM is known to efficiently induce the classical complement pathway (11). Despite this, C3 -/-and C5 -/-mice control relapsing fever Borrelia infection as efficiently as wildtype mice demonstrating that antigen-specific IgM eliminates its targets independently of complement [5, 13, 17, 18] . Although IgM is not typically known as an opsonin, the discovery of an Fc receptor (FcR) for IgM has suggested a role for IgM in opsonophagocytosis. The high-affinity Fcα/µR, which also binds the Fc region of IgA molecules, is expressed on macrophages and B cells as well as on non-hematopoietic tissues such as kidney and intestine [19] [20] [21] Vmp expressed by a related relapsing fever Borrelia, lyses bacteria in vitro, and confers a partial protection in complement-deficient mice in vivo [18] . The scFv fragments of CB515 retain the lytic activity of the parent monoclonal, demonstrating that the bactericidal activity resides in the variable region of the antibody [28] .
In this study, we examined the mechanism of B1b cell-derived antibody in control of B.
hermsii infection in vivo. Here we show that IgM-mediated phagocytosis of B. hermsii is not required for control of infection. Using a diffusion chamber model to examine host-pathogen interactions, we demonstrate that B1b cells contribute to protective immunity by producing B.
hermsii-specific antibodies that are directly bactericidal. with 6% rabbit serum (Sigma-Aldrich) at 6.67 x 10 6 bacteria/ml (1.33 x 10 6 bacteria per chamber), and chambers were sealed. Mice were anesthetized with 3% isoflurane, and using aseptic technique, chambers were implanted in a subcutaneous pocket formed by making an incision of approximately 1.5 cm in the dorsal-anterior skin of each mouse. Chambers were removed after 24 hours, and contents were collected. Bacterial density in the chamber was measured by dark-field microscopy. Chamber contents were stored at -20°C until analyzed. In some experiments, mice were passively immunized with a) 250 µl convalescent immune serum or b) treated with 14.0 units CVF one day prior to implantation as described above.
Materials and Methods

Mice
B1b cell reconstitution.
Rag1 -/-mice were reconstituted with 10 5 MACS-purified B1b cells from convalescent (i.e., resolved B. hermsii DAH infection) mice as described [15] . Fcα/µR, a specific receptor for IgM, has been shown to mediate opsonophagocytosis of IgMcoated S. aureus [19] . Since antibodies in particular IgM is critical for the protection against B.
hermsii, to examine whether Fcα/µR plays a role in IgM-mediated opsonophagocytosis, we infected mice deficient in Fcα/µR. The magnitude and duration of B. hermsii bacteremia during the first episode in these mice were comparable to that of wildtype ( Figure 1A ). Moreover, Control of B. hermsii in the absence of Fcα/µR-mediated opsonophagocytosis is independent of C3. It is known that control of relapsing fever bacteremia occurs independently of the complement system, as bacterial clearance occurs in the absence of C3 and C5 [13] . These results suggest that complement either does not contribute to clearance or that other mechanisms such as opsonophagocytosis operate in a redundant fashion. To examine whether complement-mediated lysis or complement-mediated opsonophagocytosis was plays a critical function in the absence of Fcα/µR-mediated opsonophagocytosis, we depleted C3 in wildtype and Fcα/µR -/-mice with cobra venom factor (CVF). One day prior to infection, mice were treated with 30 µg of CVF (14.0 units) i.p., which is sufficient to deplete C3 to less than 5% of normal levels for four days [29, 30] . At three days post-infection, mice were treated with the same dose to maintain C3 depletion. Despite a deficiency in both Fcα/µR and C3, the magnitude of the bacteremia was similar in CVF-treated and -untreated wildtype and Fcα/µR -/-mice ( Figure 2 ).
These results indicate that the effector mechanism of B. hermsii-specific IgM is neither C3-nor Fcα/µR-dependent.
Antibody-mediated control of B. hermsii does not require phagocytic cell contact. Since Figure 3A . After 24 hours in naïve mice, the number of bacteria in each chamber was approximately threefold higher than the initial number in each chamber. In contrast, the number of bacteria in chambers implanted in convalescent mice was nearly undetectable ( Figure   3B ).
The numbers of B. hermsii were also reduced significantly in the chambers implanted in passively immunized mice ( Figure 3B) . Interestingly, the degree of bacterial killing in these mice was to a lesser extent than what was observed in the chambers implanted in convalescent mice, suggesting that the amount of specific IgM present in the chamber had a direct effect on bacterial killing inside the chambers. Therefore, we examined specific IgM levels in the chambers taken from naïve mice, convalescent mice, and naïve mice that were given convalescent immune serum. As expected, we found that specific IgM had entered the chambers implanted in convalescent mice and passively immunized naïve mice. Furthermore, increasing amounts of specific IgM in each chamber inversely correlated with bacterial viability ( Figure 3C ). These results demonstrate that lysis of B. hermsii in diffusion chambers is IgM-dependent and does not require cell contact.
Killing of B. hermsii in diffusion chambers is C3-independent. As described above, IgM controls B. hermsii independent of C3 or Fcα/µR-mediated opsonophagocytosis. To test whether cell contact-independent killing of B. hermsii in diffusion chambers is also complement independent, we depleted C3 in naïve and convalescent wildtype mice with CVF one day prior to implantation of diffusion chambers. As expected, bacterial growth was unhindered in naïve mice regardless of whether complement was depleted (Figure 4 ). In contrast, there were no bacteria remaining in chambers removed from convalescent mice irrespective of the presence of C3
( Figure 4A ).
To independently confirm that IgM is bactericidal in vivo independent of the complement system, we used mice deficient in both the alternative and classical complement pathways due to a targeted deletion in C3. Diffusion chambers containing 1.33 x 10 6 B. hermsii bacteria were implanted into convalescent wildtype and C3 -/-mice. In agreement with the above results, bacteria in diffusion chambers were killed in both wildtype and C3 -/-mice ( Figure 4B ). These results demonstrate that C3 is not required for antibody-mediated lysis of B. hermsii in the diffusion chambers.
B1b cell-derived antibodies are sufficient to kill B. hermsii in diffusion chambers. Clearance of B. hermsii is T cell-independent, and expansion of the peritoneal B1b cell pool is observed concurrent with the resolution of infection [15] . B1b cells exhibit TI memory, and reinfection with B. hermsii results in the rapid generation of specific IgM that is capable of controlling disease in the absence of any other adaptive immune cells [15] . To determine whether B1b-derived IgM is capable of clearing B. hermsii independently of opsonophagocytosis, we tested whether IgM generated by adoptively transferred convalescent B1b cells was able to kill B.
hermsii in diffusion chambers.
Rag1
-/-mice reconstituted with purified convalescent B1b cells and primed with B.
hermsii generated a B. hermsii-specific IgM response ( Figure 5A ). To measure cell-independent killing by B1b-derived IgM, we implanted diffusion chambers containing 1.33 x 10 6 spirochetes in reconstituted Rag1 -/-mice at ten days post-infection. As expected, B. hermsii bacteria in diffusion chambers proliferated vigorously when implanted in unreconstituted Rag1 -/-recipients.
On the other hand, we observed a significant decrease in the number of live bacteria in chambers implanted in mice reconstituted with convalescent B1b cells ( Figure 5B ). These results demonstrate that IgM generated by B1b cells is directly bactericidal in vivo.
Discussion
IgM is the dominant isotype secreted upon antigen encounter and plays a critical role in immunity to a number of infections [2] . The production of specific IgM is required and sufficient to control bacteremia during relapsing fever infection [14, 15] . We have previously shown that B1b cells generate B. hermsii-specific IgM that is capable of controlling B. hermsii bacteremia.
Here we show that the IgM-mediated control of B. hermsii bacteremia is independent of Fcα/µR and C3 and does not require cell contact. Our data indicate that the mechanism of B1b-mediated control of B. hermsii is through the secretion of bactericidal antibodies. 
